SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...

Bionano Genomics Inc. (NASDAQ:BNGO) stock has tumbled to a 52-week low, touching down at $4.9 as the company faces a challenging market environment. According to InvestingPro data, the stock's RSI ...

Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading lower Monday. The company's stock began trading on a reverse split-adjusted basis on Monday. Erica Kollmann Over $1M Bet On Bioventus?

Gene sequencing company Bionano Genomics (NASDAQ:BNGO) traded ~8% lower in the premarket on Thursday after announcing a 1-for-60 reverse stock split that will take effect on Friday at 5 p.m.

Bionano Genomics (BNGO) announced a study published in the American Journal of Hematology demonstrating the potential utility of optical genome ...

BNGO opened at $4.08 on Monday ... a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $11.15 million, a price-to-earnings ratio of -0.03 and ...

Bionano Genomics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods. There have been no specific sales or earnings ...

Shares of BNGO stock opened at $4.16 on Monday. The stock’s 50-day simple moving average is $9.29 and its 200-day simple moving average is $16.99. The company has a debt-to-equity ratio of 0.07 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...